DK253688D0 - MEDICINAL USE FOR TREATMENT OF ATHEROSCLEROSIS - Google Patents

MEDICINAL USE FOR TREATMENT OF ATHEROSCLEROSIS

Info

Publication number
DK253688D0
DK253688D0 DK253688A DK253688A DK253688D0 DK 253688 D0 DK253688 D0 DK 253688D0 DK 253688 A DK253688 A DK 253688A DK 253688 A DK253688 A DK 253688A DK 253688 D0 DK253688 D0 DK 253688D0
Authority
DK
Denmark
Prior art keywords
atherosclerosis
treatment
medicinal use
medicinal
Prior art date
Application number
DK253688A
Other languages
Danish (da)
Other versions
DK253688A (en
Inventor
Stanley J Dudrick
Original Assignee
Dudrick Medical Research Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dudrick Medical Research Fund filed Critical Dudrick Medical Research Fund
Publication of DK253688D0 publication Critical patent/DK253688D0/en
Publication of DK253688A publication Critical patent/DK253688A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Exposure Of Semiconductors, Excluding Electron Or Ion Beam Exposure (AREA)
DK253688A 1986-09-10 1988-05-09 MEDICINAL USE FOR TREATMENT OF ATHEROSCLEROSIS DK253688A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90593486A 1986-09-10 1986-09-10
PCT/US1987/002279 WO1988001872A1 (en) 1986-09-10 1987-09-08 Method and substrate composition for treating atherosclerosis

Publications (2)

Publication Number Publication Date
DK253688D0 true DK253688D0 (en) 1988-05-09
DK253688A DK253688A (en) 1988-05-09

Family

ID=25421711

Family Applications (1)

Application Number Title Priority Date Filing Date
DK253688A DK253688A (en) 1986-09-10 1988-05-09 MEDICINAL USE FOR TREATMENT OF ATHEROSCLEROSIS

Country Status (8)

Country Link
KR (1) KR880701558A (en)
CN (1) CN87106235A (en)
AU (1) AU8033487A (en)
CA (1) CA1290692C (en)
DK (1) DK253688A (en)
IL (1) IL83822A0 (en)
WO (1) WO1988001872A1 (en)
ZA (1) ZA876782B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620567B2 (en) * 1987-10-06 1992-02-20 Sharpe Research Pty. Limited Prevention of soft tissue damage
DE3916903A1 (en) * 1989-05-24 1991-02-28 Leopold Pharma Gmbh WAESSER COMPOSITION FOR PARENTERAL NUTRITION
AT394135B (en) * 1989-06-22 1992-02-10 Leopold Pharma Gmbh Aqueous amino acid solution for parenteral alimentation
AU655780B2 (en) * 1990-10-30 1995-01-12 Clintec Nutrition Company A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5702065A (en) * 1994-01-21 1997-12-30 Gigatek Memory Systems Tape cartridge with reduced tangential drive force
AU2001294245B2 (en) * 2000-10-13 2006-09-21 Chugai Seiyaku Kabushiki Kaisha Compositions for improving lipid metabolism
US20040265358A1 (en) * 2001-12-21 2004-12-30 Petra Verhoef Modified methionine rich food products and process for their manufacture
CN103768601A (en) * 2012-10-22 2014-05-07 中国科学院上海生命科学研究院 Method for preventing and treating atherosclerosis through inhibition of micro-RNA155
CN110389231B (en) * 2018-04-19 2022-09-06 北京市心肺血管疾病研究所 Application of branched chain amino acid detection substance in preparation of post-operation prognosis risk assessment kit for aortic dissection patient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965542A (en) * 1958-02-12 1960-12-20 Castaigne Albert Pharmaceutical product for reducing the proportion of cholesterol in the blood
US3574857A (en) * 1968-04-01 1971-04-13 Smith Kline French Lab Antilipidemic methods using glutamic acid,threonine and proline
DE3228127A1 (en) * 1982-07-28 1984-02-02 Basf Ag, 6700 Ludwigshafen Amino acid solutions for infusion

Also Published As

Publication number Publication date
WO1988001872A1 (en) 1988-03-24
IL83822A0 (en) 1988-02-29
ZA876782B (en) 1988-09-28
CA1290692C (en) 1991-10-15
KR880701558A (en) 1988-11-03
CN87106235A (en) 1988-05-18
AU8033487A (en) 1988-04-07
DK253688A (en) 1988-05-09

Similar Documents

Publication Publication Date Title
DK63688A (en) WASTE TREATMENT PROCEDURES
DK198588D0 (en) PROCEDURE FOR WASTE TREATMENT
DK333788D0 (en) PHARMACEUTICAL PREPARATION FOR TREATMENT OF DAMAGED CARTRIC TISSUE
DK405286D0 (en) USING DOUBLE-STRENGTH RNA FOR TREATMENT OF AIDS
DK96090D0 (en) DEVICE FOR TREATMENT OF MEDICAL WASTE
IT8748236A0 (en) PROCEDURE FOR RECOVERY OF WASTE CONCRETE
DK253688A (en) MEDICINAL USE FOR TREATMENT OF ATHEROSCLEROSIS
DK428586A (en) PROCEDURE FOR BIOLOGICAL TREATMENT OF WASTE WATER
DK162121C (en) PROCEDURE FOR TREATMENT OF WASTE PRODUCTS
DK496687A (en) APPLICATION OF MEDETOMIDIN FOR THE PREPARATION OF MEDICINAL PRODUCTS FOR USE IN THE TREATMENT OF ANTI-DISEASES
DK298187A (en) APPLICANT FOR TREATMENT OF LAEBER
DK87888A (en) THERAPEUTIC USE OF TINDIODDEUTEROPORFYRIN
DK232788D0 (en) PROCEDURE FOR BIOLOGICAL TREATMENT OF WASTE WATER
DK484186A (en) PROCEDURE FOR THE PREPARATION OF A PREPARATION FOR THE TREATMENT OF PSORIASIS
DK593287D0 (en) PROCEDURE FOR CLEANING OF ROEGGAS
DK625486A (en) PROCEDURE FOR CLEANING OF ROEGGAS
NO861346L (en) PROCEDURE FOR DISPOSAL OF WASTE.
DK17590A (en) FUSIDIC ACID FOR USE IN TREATMENT OF AIDS
DK441987D0 (en) PHARMACEUTICAL PREPARATION FOR TREATMENT OF CEREBRAL ISCHAEMI
DK302887D0 (en) PREPARATION OF MEDICINALS FOR TREATING INFECTIOUS DISEASES
DK401589D0 (en) PROCEDURES FOR TREATMENT OF ORIGINAL CARBASSES
DK417587D0 (en) PROCEDURE FOR BIOLOGICAL TREATMENT OF WASTE WATER USING A PRINCIPLE OF THE CASCHING PRINCIPLE
DK323286A (en) TABLE OF USE FOR USING PLASMA MASKING
DK200885D0 (en) APPLICATION FOR USE FOR GRANULATION OF FOAMSTUFFS
RO94514A2 (en) PROCEDURE FOR TREATMENT OF NAMOLS

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment